Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A. Inc. named Ramona Sequeira as president of the United States Business Unit. Sequeira will lead all business operations for the U.S., and will report to Christophe Weber, the president/CEO of Takeda.
"The U.S. is a critical market for Takeda's future growth, and I am confident that with her strong commercial experience and knowledge of the U.S. healthcare environment, Ramona is the right person to lead this important business unit and play a key role on my leadership team," said Weber. "Her more than 20 years of leadership experience and track record of success across multiple healthcare markets, as well as her demonstrated passion for patient centricity, will serve as a critical foundation during Takeda's global transformation."
Sequeira brings extensive leadership experience across multiple therapy areas including neuroscience, specialty and primary care, and several regions including the U.S., Canada and UK. Her most recent role was vice president, Lilly USA at Eli Lilly and Company. Previous to that, she was general manager of Lilly's UK Hub.
Read the full release